TF and neoplasm: A mammary fat pad-enhanced derivative of the triple negative breast cancer cell line MDA-MB-231 (MDA-MB-231 mfp) with markedly improved tumor growth properties was previously characterized [40] and used to study contributions of TF-FVIIa-PAR2 coagulation protease signaling pathways to tumor progression [8].